Shandong Lukang Pharmaceutical Co Ltd (600789) — Cash Flow-to-Debt Ratio
Shandong Lukang Pharmaceutical Co Ltd (600789) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-6.39 Million could theoretically repay 0% of its total liabilities (CN¥4.71 Billion) in one year. See Shandong Lukang Pharmaceutical Co Ltd (600789) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Lukang Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shandong Lukang Pharmaceutical Co Ltd across 28 annual periods. Also explore 600789 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Shandong Lukang Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Shandong Lukang Pharmaceutical Co Ltd (600789) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥698.17 Million | CN¥4.78 Billion | ▲ +82.7% |
| 2024 | 0.08x | CN¥402.82 Million | CN¥5.04 Billion | ▼ -33.0% |
| 2023 | 0.12x | CN¥604.01 Million | CN¥5.06 Billion | ▲ +40.2% |
| 2022 | 0.09x | CN¥444.38 Million | CN¥5.22 Billion | ▲ +150.3% |
| 2021 | 0.03x | CN¥149.33 Million | CN¥4.39 Billion | ▼ -43.2% |
| 2020 | 0.06x | CN¥234.55 Million | CN¥3.91 Billion | ▼ -35.1% |
| 2019 | 0.09x | CN¥361.87 Million | CN¥3.92 Billion | ▼ -8.0% |
| 2018 | 0.10x | CN¥351.09 Million | CN¥3.50 Billion | ▲ +13.1% |
| 2017 | 0.09x | CN¥275.51 Million | CN¥3.10 Billion | ▼ -34.2% |
| 2016 | 0.13x | CN¥296.23 Million | CN¥2.20 Billion | ▲ +263.6% |
| 2015 | 0.04x | CN¥78.39 Million | CN¥2.11 Billion | ▼ -11.8% |
| 2014 | 0.04x | CN¥108.56 Million | CN¥2.58 Billion | ▼ -60.0% |
| 2013 | 0.11x | CN¥256.50 Million | CN¥2.44 Billion | ▲ +117.0% |
| 2012 | 0.05x | CN¥115.20 Million | CN¥2.38 Billion | ▼ -29.8% |
| 2011 | 0.07x | CN¥123.28 Million | CN¥1.79 Billion | ▼ -69.9% |
| 2010 | 0.23x | CN¥308.88 Million | CN¥1.35 Billion | ▲ +6.8% |
| 2009 | 0.21x | CN¥199.49 Million | CN¥930.38 Million | ▲ +2.5% |
| 2008 | 0.21x | CN¥209.39 Million | CN¥1.00 Billion | ▲ +59.8% |
| 2007 | 0.13x | CN¥137.30 Million | CN¥1.05 Billion | ▲ +134.3% |
| 2006 | 0.06x | CN¥56.24 Million | CN¥1.01 Billion | ▼ -62.4% |
| 2005 | 0.15x | CN¥161.64 Million | CN¥1.09 Billion | ▲ +182.8% |
| 2004 | 0.05x | CN¥63.24 Million | CN¥1.20 Billion | ▼ -66.0% |
| 2003 | 0.15x | CN¥167.42 Million | CN¥1.08 Billion | ▼ -46.0% |
| 2002 | 0.29x | CN¥315.59 Million | CN¥1.10 Billion | ▲ +29.1% |
| 2001 | 0.22x | CN¥270.43 Million | CN¥1.22 Billion | ▲ +1031.5% |
| 2000 | 0.02x | CN¥22.36 Million | CN¥1.14 Billion | ▼ -61.3% |
| 1999 | 0.05x | CN¥35.12 Million | CN¥691.92 Million | ▼ -52.1% |
| 1998 | 0.11x | CN¥46.18 Million | CN¥435.91 Million | — |